Virus particles in marmoset hepatitis.

Assembly of hepatitis delta virus particles.

An inactivated hepatitis A virus vaccine prepared from infected marmoset liver.

Infectious particles in hepatitis.

Expression and characterization of hepatitis E virus-like particles and non-virus-like particles from insect cells.

Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies.

Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles.

Support of the infectivity of hepatitis delta virus particles by the envelope proteins of different genotypes of hepatitis B virus.

Presentation of hepatitis B virus preS2 epitope on bluetongue virus core-like particles.

Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles.

Rolling circular DNA associated with Dane particles in hepatitis B virus.

Amphipathic α-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles.

Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection.

The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.

Induction of antibody and interferon-γ production in mice immunized with virus-like particles of swine hepatitis E virus.

Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.

hepatitis C virus (HCV) subviral envelope particles induce efficient anti-HCV antibody production in animals pre-immunized with HBV vaccine.

Assembly Pathway of Hepatitis B Core Virus-like Particles from Genetically Fused Dimers.

Agarose gel filtration of concentrated fecal extracts containing virus-like particles associated with hepatitis A.

Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles.

Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles.

Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles.

Hepatitis B virus capsid particles are assembled from core-protein dimer precursors.

Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles.

Biochemical characterization of Australia antigen. Evidence for defective particles of hepatitis B virus.

Suggest Documents

Assembly of hepatitis delta virus particles.

An inactivated hepatitis A virus vaccine prepared from infected marmoset liver.

Infectious particles in hepatitis.

Expression and characterization of hepatitis E virus-like particles and non-virus-like particles from insect cells.

Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies.

Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles.

Support of the infectivity of hepatitis delta virus particles by the envelope proteins of different genotypes of hepatitis B virus.

Presentation of hepatitis B virus preS2 epitope on bluetongue virus core-like particles.

Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles.

Rolling circular DNA associated with Dane particles in hepatitis B virus.

Amphipathic α-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles.

Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection.

The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.

Induction of antibody and interferon-γ production in mice immunized with virus-like particles of swine hepatitis E virus.

Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.

hepatitis C virus (HCV) subviral envelope particles induce efficient anti-HCV antibody production in animals pre-immunized with HBV vaccine.

Assembly Pathway of Hepatitis B Core Virus-like Particles from Genetically Fused Dimers.

Agarose gel filtration of concentrated fecal extracts containing virus-like particles associated with hepatitis A.

Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles.

Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles.

Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles.

Hepatitis B virus capsid particles are assembled from core-protein dimer precursors.

Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles.

Biochemical characterization of Australia antigen. Evidence for defective particles of hepatitis B virus.

Virus particles in marmoset hepatitis.

Recommend Documents

Follow Us